4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-24-094009
Director sold 14,508 shares at $50.01 ($725,526)
- Director acquired 14,508 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
GOOD JENNIFER L · Director
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-08-26 | Exercise or conversion : show line 1 in the form 10b5-1 | +2,100 | $22.93 | $48,153 | 5,100 | D |
| 2024-08-26 | Exercise or conversion : show line 2 in the form 10b5-1 | +4,945 | $21.37 | $105,675 | 10,045 | D |
| 2024-08-26 | Exercise or conversion : show line 3 in the form 10b5-1 | +5,763 | $18.99 | $109,439 | 15,808 | D |
| 2024-08-26 | Exercise or conversion : show line 4 in the form 10b5-1 | +1,700 | $4.15 | $7,055 | 17,508 | D |
| 2024-08-26 | Sale : show line 5 in the form 10b5-1 | −14,508 | $50.01 | $725,526 | 3,000 | D |
| Open-market sales · 14,508 sh · avg $50.01 · $725,526 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-08-26 | Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (right to buy) | −2,100 | 27,900 | D |
| 2024-08-26 | Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (right to buy) | −4,945 | 13,555 | D |
| 2024-08-26 | Exercise or conversion : show line 8 in the form 10b5-1 Stock Option (right to buy) | −5,763 | 9,237 | D |
| 2024-08-26 | Exercise or conversion : show line 9 in the form 10b5-1 Stock Option (right to buy) | −1,700 | 18,300 | D |
Loading xslF345X05/tm2422915-1_4seq1.xml…